Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kura Oncology Inc
KURACurrent price
15.92 USD
-0.57 USD (-3.46%)
Last closed
16.49 USD
Company
kuraoncology.com
ISIN
US50127T1097
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 374 864 000 USD
Yield for 12 month
+75.14 %
1Y
3Y
5Y
10Y
15Y
KURA
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, an orally bioavailable small molecule inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a farnesyl transferase inhibitor for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification. The company was founded in 2014 and is headquartered in San Diego, California. Address: 12730 High Bluff Drive, San Diego, CA, United States, 92130
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30.43 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-849 000 USD
Last Year
-759 000 USD
Current Quarter
–
Last Quarter
-202 000 USD
Key Figures KURA
1 year
3 years
5 years
10 years
EBITDA
-216 644 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.54 %
PEG Ratio
–
Return On Equity TTM
-46.28 %
Wall Street Target Price
30.43 USD
Revenue TTM
–
Book Value
5.45 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.35 USD
Diluted Eps TTM
-2.35 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics KURA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History KURA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation KURA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-2.4793
Price Book MRQ
3.2444
Financials KURA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators KURA
For 52 weeks
8.8 USD
24.17 USD
50 Day MA
18.78 USD
Shares Short Prior Month
10 189 166
200 Day MA
20.17 USD
Short Ratio
18.16
Shares Short
9 292 585
Short Percent
12.25 %
BeatStart